Shattuck Labs, Inc. Business Operations Contracts & Agreements
6 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Indemnification Agreements (1)
- Sales Agreements (1)
- Services Agreements (1)
- Termination Agreements (1)
- Clinical Trial Collaboration and Supply Agreement, dated February 4, 2022, by and between Shattuck Labs, Inc. and ImmunoGen, Inc (Filed With SEC on February 23, 2023)
- Sales Agreement, dated July 29, 2022, between Shattuck Labs, Inc. and SVB Securities LLC (Filed With SEC on July 29, 2022)
- Takeda Termination Agreement (Filed With SEC on November 9, 2021)
- Form of Indemnification Agreement for directors and executive officers (Filed With SEC on October 5, 2020)
- Master Services Agreement, dated March 31, 2017, between Shattuck Labs, Inc. and KBI Biopharma, Inc (Filed With SEC on September 18, 2020)
- Collaboration Agreement, dated August 8, 2017, by and between Shattuck Labs, Inc. and Millennium Pharmaceuticals, Inc., as amended (Filed With SEC on September 18, 2020)
